• 1
    Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ ASE 2003 guideline update for the clinical application of echocardiography—summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol. 2003;42:954970.
  • 2
    Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol. 2003;42:13181333.
  • 3
    Dillier R, Zuber M, Arand P, et al. Assessment of systolic and diastolic function in heart failure using ambulatory monitoring with acoustic cardiography. Ann Med. 2011;43:403411.
  • 4
    Collins SP, Kontos MC, Michaels AD, et al. Utility of a bedside acoustic cardiographic model to predict elevated left ventricular filling pressure. Emerg Med J. 2010;27:677682.
  • 5
    Erne P. Beyond auscultation—acoustic cardiography in the diagnosis and assessment of cardiac disease. Swiss Med Wkly. 2008;138:439452.
  • 6
    Toggweiler S, Zuber M, Erne P. Optimization of atrioventricular and interventricular delay with acoustic cardiography in biventricular pacing. Congest Heart Fail. 2006;12(suppl 1):3740.
  • 7
    Roos M, Toggweiler S, Zuber M, et al. Acoustic cardiographic parameters and their relationship to invasive hemodynamic measurements in patients with left ventricular systolic dysfunction. Congest Heart Fail. 2006;12(suppl 1):1924.
  • 8
    Zuber M, Kipfer P, Attenhofer Jost CH. Usefulness of acoustic cardiography to resolve ambiguous values of B-type natriuretic peptide levels in patients with suspected heart failure. Am J Cardiol. 2007;100:866869.
  • 9
    Gardin JM, Adams DB, Douglas PS, et al. Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report. J Am Soc Echocardiogr. 2002;15:275290.
  • 10
    Von Hoff DD, Layard MW, Basa P, et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med. 1979;91:710717.
  • 11
    Bristow MR, Mason JW, Billingham ME, et al. Dose-effect and structure-function relationships in doxorubicin cardiomyopathy. Am Heart J. 1981;102:709718.
  • 12
    Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer. 2003;97:28692879.
  • 13
    Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med. 1998;339:900905.
  • 14
    Sabel MS, Levine EG, Hurd T, et al. Is MUGA scan necessary in patients with low-risk breast cancer before doxorubicin-based adjuvant therapy? Multiple gated acquisition. Am J Clin Oncol. 2001;24:425428.
  • 15
    Porea TJ, Dreyer ZE, Bricker JT, et al. Evaluation of left ventricular function in asymptomatic children about to undergo anthracycline-based chemotherapy for acute leukemia: an outcome study. J Pediatr Hematol Oncol. 2001;23:420423.
  • 16
    Iarussi D, Galderisi M, Ratti G, et al. Left ventricular systolic and diastolic function after anthracycline chemotherapy in childhood. Clin Cardiol. 2001;24:663669.
  • 17
    Stoodley PW, Richards DA, Meikle SR, et al. The potential role of echocardiographic strain imaging for evaluating cardiotoxicity due to cancer therapy. Heart Lung Circ. 2011;20:39.
  • 18
    Sawaya H, Sebag IA, Plana JC, et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol. 2011;107:13751380.
  • 19
    Poterucha JT, Kutty S, Lindquist RK, et al. Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction. J Am Soc Echocardiogr. 2012;25:733740.
  • 20
    Oberholzer K, Kunz RP, Dittrich M, et al. Anthracycline-induced cardiotoxicity: cardiac MRI after treatment for childhood cancer [in German]. Rofo. 2004;176:12451250.
  • 21
    Roos M, Toggweiler S, Jamshidi P, et al. Noninvasive detection of left ventricular systolic dysfunction by acoustic cardiography in cardiac failure patients. J Card Fail. 2008;14:310319.
  • 22
    Jamshidi P, Kobza R, Toggweiler S, et al. Impact of preload changes on positive and negative left ventricular dP/dt and systolic time intervals: preload changes on left ventricular function. Indian Heart J. 2012;64:314318.
  • 23
    Reil JC, Hohl M, Reil GH, et al. Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction [published online ahead of print July 24, 2012]. Eur Heart J. doi: 10.1093/eurheartj/ehs218.
  • 24
    Yip GW, Zhang Q, Xie JM et al. Resting global and regional left ventricular contractility in patients with heart failure and normal ejection fraction: insights from speckle-tracking echocardiography. Heart. 2011;97:287294.